Last reviewed · How we verify

Fluoxetine+Olanzapine — Competitive Intelligence Brief

Fluoxetine+Olanzapine (Fluoxetine+Olanzapine) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: SSRI + atypical antipsychotic combination. Area: Psychiatry.

marketed SSRI + atypical antipsychotic combination Serotonin transporter (SERT), dopamine D2 receptor, serotonin 5-HT2A receptor Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Fluoxetine+Olanzapine (Fluoxetine+Olanzapine) — University Health Network, Toronto. Fluoxetine inhibits serotonin reuptake while olanzapine blocks dopamine and serotonin receptors, combining antidepressant and antipsychotic effects.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fluoxetine+Olanzapine TARGET Fluoxetine+Olanzapine University Health Network, Toronto marketed SSRI + atypical antipsychotic combination Serotonin transporter (SERT), dopamine D2 receptor, serotonin 5-HT2A receptor
Escitalopram+Aripiprazole Escitalopram+Aripiprazole Ministry of Health & Welfare, Korea marketed SSRI + atypical antipsychotic combination Serotonin transporter (SERT); dopamine D2 receptor; serotonin 5-HT1A receptor
Sertraline + Olanzapine Sertraline + Olanzapine Weill Medical College of Cornell University marketed SSRI + atypical antipsychotic combination Serotonin transporter (SERT); dopamine D2 receptor; serotonin 5-HT2A receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (SSRI + atypical antipsychotic combination class)

  1. Ministry of Health & Welfare, Korea · 1 drug in this class
  2. University Health Network, Toronto · 1 drug in this class
  3. Weill Medical College of Cornell University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fluoxetine+Olanzapine — Competitive Intelligence Brief. https://druglandscape.com/ci/fluoxetine-olanzapine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: